Search Results - "Weiss, Mark A"

Did border closures slow SARS-CoV-2? by Shiraef, Mary A., Friesen, Paul, Feddern, Lukas, Weiss, Mark A.

“…Despite the economic, social, and humanitarian costs of border closures, more than 1000 new international border closures were introduced in response to the…”
Get full text

Immunotherapy in acute myeloid leukemia by Grosso, Dolores A., Hess, Rosemary C., Weiss, Mark A.

“…Despite the remarkable progress made in some leukemias such as CML and CLL, cytotoxic treatment for AML remains essentially unchanged over the last 4 decades…”
Get full text

COVID Border Accountability Project, a hand-coded global database of border closures introduced during 2020 by Shiraef, Mary A., Hirst, Cora, Weiss, Mark A., Naseer, Sarah, Lazar, Nikolas, Beling, Elizabeth, Straight, Erin, Feddern, Lukas, Taylor, Noah Rusk, Jackson, Cayleigh, Yu, William, Bhaskaran, Aadya, Mattar, Layth, Amme, Matthew, Shum, Maggie, Mitsdarffer, Mary Louise, Sweere, Johanna, Brantley, Susanna E., Schenoni, Luis L., Lewis-Beck, Colin

“…Quantifying the timing and content of policy changes affecting international travel and immigration is key to ongoing research on the spread of SARS-CoV-2 and…”
Get full text

Pentostatin, Cyclophosphamide, and Rituximab Is an Active, Well-Tolerated Regimen for Patients With Previously Treated Chronic Lymphocytic Leukemia by LAMANNA, Nicole, KALAYCIO, Matt, SCHEINBERG, David A, WEISS, Mark A, MASLAK, Peter, JURCIC, Joseph G, HEANEY, Mark, BRENTJENS, Renier, ZELENETZ, Andrew D, HORGAN, Denise, GENCARELLI, Alison, PANAGEAS, Katherine S

“…Purine analogs and alkylators are important agents for treating chronic lymphocytic leukemia (CLL). Early studies combining fludarabine and chlorambucil were…”
Get full text

Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses by LAMANNA, Nicole, JURCIC, Joseph G, ZELENETZ, Andrew D, WEISS, Mark A, NOY, Ariela, MASLAK, Peter, GENCARELLI, Alison N, PANAGEAS, Katherine S, HEANEY, Mark L, BRENTJENS, Renier J, GOLDE, David W, SCHEINBERG, David A

“…Modern combination strategies are active in chronic lymphocytic leukemia (CLL) but can have significant myelosuppression and immunosuppression that may require…”
Get full text

Presentation of the PATH Alliance® registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections by Horn, David L, Fishman, Jay A, Steinbach, William J, Anaissie, Elias J, Marr, Kieren A, Olyaei, Ali J, Pfaller, Michael A, Weiss, Mark A, Webster, Karen M, Neofytos, Dionissios

“…Abstract Randomized clinical trials for patients with invasive fungal infections (IFIs) are often limited or precluded, necessitating alternate sources of…”
Get full text

Inflammatory Myofibroblastic Tumors of the Kidney: A Clinicopathologic and Immunohistochemical Study of 12 Cases by Kapusta, Linda R, Weiss, Mark A, Ramsay, Jennifer, Lopez-Beltran, Antonio, Srigley, John R

“…Inflammatory myofibroblastic tumor is a rare entity composed of spindle cells admixed with variable amounts of extracellular collagen, lymphocytes, and plasma…”
Get full text

Pentostatin and Cyclophosphamide: An Effective New Regimen in Previously Treated Patients With Chronic Lymphocytic Leukemia by WEISS, Mark A, MASLAK, Peter G, JURCIC, Joseph G, SCHEINBERG, David A, ALIFF, Timothy B, LAMANNA, Nicole, FRANKEL, Stanley R, KOSSMAN, Steven E, HORGAN, Denise

“…Purine analogs and alkylators are important agents in the treatment of chronic lymphocytic leukemia (CLL). Previously, combinations of fludarabine and…”
Get full text

Real‐world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres by Mato, Anthony, Nabhan, Chadi, Kay, Neil E., Weiss, Mark A., Lamanna, Nicole, Kipps, Thomas J., Grinblatt, David L., Flinn, Ian W., Kozloff, Mark F., Flowers, Christopher R., Farber, Charles M., Kiselev, Pavel, Swern, Arlene S., Sullivan, Kristen, Flick, E. Dawn, Sharman, Jeff P.

“…Summary The clinical course of chronic lymphocytic leukaemia (CLL) is heterogeneous, and treatment options vary considerably. The Connect® CLL registry is a…”
Get full text

Posttreatment interleukin‐2 in patients with acute myeloid leukemia: The end of a long road for patients and clinical trials? by Grosso, Dolores, Weiss, Mark A.

“…For over 2 decades, a series of clinical trials has tested the efficacy of interleukin‐2 as postremission therapy for patients with acute myeloid leukemia. In…”
Get full text

Neanderthal and Denisova genetic affinities with contemporary humans: Introgression versus common ancestral polymorphisms by Lowery, Robert K., Uribe, Gabriel, Jimenez, Eric B., Weiss, Mark A., Herrera, Kristian J., Regueiro, Maria, Herrera, Rene J.

“…Analyses of the genetic relationships among modern humans, Neanderthals and Denisovans have suggested that 1–4% of the non-Sub-Saharan African gene pool may be…”
Get full text

Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature by Pathak, Priyanka, Hess, Rosemary, Weiss, Mark A.

“…Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies that arise from clonal proliferation of immature lymphoid cells in the…”
Get full text

Characterizing and prognosticating chronic lymphocytic leukemia in the elderly: prospective evaluation on 455 patients treated in the United States by Nabhan, Chadi, Mato, Anthony, Flowers, Christopher R, Grinblatt, David L, Lamanna, Nicole, Weiss, Mark A, Davids, Matthew S, Swern, Arlene S, Bhushan, Shriya, Sullivan, Kristen, Flick, E Dawn, Kiselev, Pavel, Sharman, Jeff P

“…Median age at diagnosis of patients with chronic lymphocytic leukemia (CLL) is > 70 years. However, the majority of clinical trials do not reflect the…”
Get full text

Treatment of Adults With Acute Lymphoblastic Leukemia: Do the Specifics of the Regimen Matter?: Results From a Prospective Randomized Trial by LAMANNA, Nicole, HEFFNER, Leonard T, WEISS, Mark A, KALAYCIO, Matt, SCHILLER, Gary, COUTRE, Steven, MOORE, Joseph, SEITER, Karen, MASLAK, Peter, PANAGEAS, Katherine, GOLDE, David

“…Induction therapy for adults with acute lymphoblastic leukemia (ALL) is similar across essentially all regimens, comprised of vincristine, corticosteroids, and…”
Get full text

Refractory aspergillus pneumonia in patients with acute leukemia: Successful therapy with combination caspofungin and liposomal amphotericin by ALIFF, Timothy B, MASLAK, Peter G, JURCIC, Joseph G, HEANEY, Mark L, CATHCART, Kathleen N, SEPKOWITZ, Kent A, WEISS, Mark A

“…Pulmonary aspergillosis and other invasive fungal infections (IFIs) commonly complicate the management of patients with acute leukemia. Standard…”
Get full text

Pentostatin in chronic lymphocytic leukemia by Sauter, Craig, Lamanna, Nicole, Weiss, Mark A

“…Chronic lymphocytic leukemia (CLL) is a disease that typically afflicts older individuals with a median age of diagnosis in the eighth decade of life for which…”
Get more information

Consolidation and maintenance rituximab therapy in chronic lymphocytic leukemia by Lamanna, Nicole, Weiss, Mark A.

Get full text

The Warburg Effect Confers Adverse Outcome in Chronic Lymphocytic Leukemia by Gardner, Jeffrey R, Devlin, Sean M, Knapp, Kristina, Bauli, Francesco, Patel, Minal, Lamanna, Nicole, Frattini, Mark G, Brentjens, Renier, Maslak, Peter, Jurcic, Joseph G, Weiss, Mark A, Abdel-Wahab, Omar, Scheinberg, David A, Heaney, Mark L

Get full text

Chemoimmunotherapy with modified dosing of fludarabine, cyclophosphamide, and rituximab shows significant clinical activity in patients with previously untreated chronic lymphocytic leukemia by Lamanna, Nicole, Weiss, Mark A.

Get full text

In adult ALL, less is now more by Weiss, Mark A, Lamanna, Nicole

“…Comment on Brüggemann et al, page 1116 Most adults with ALL achieve a CR but then relapse from clinically inapparent MRD. The ability to predict who will…”
Get full text